The cost-effectiveness of risedronate in
The cost-effectiveness of risedronate in the treatment of osteoporosis: an international perspective
β
F. BorgstrΓΆm; Γ
. Carlsson; H. Sintonen; S. Boonen; P. Haentjens; R. Burge; O. Jo
π
Article
π
2006
π
Springer-Verlag
π
English
β 226 KB